Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
Sponsored by University of Virginia
The purpose of this study is to create new tests to identify biomarkers for ovarian cancer so that a screening test can be developed. For patients who have a diagnosis of ovarian Cancer, researchers will use blood samples before and after treatment to see if disease status can be determined by measuring the amount of biomarker.
Subjects must fall into one of the following groups:
Women at increased risk of ovarian cancer based on family history, personal history, or genetic factors defined as either BRCA1 or BRCA2 mutations who still retain both fallopian tubes and both ovaries
Women at average risk for ovarian cancer
Women with known or suspected ovarian cancer who are undergoing evaluation and/or treatment at UVA Cancer Center
History of prior malignancy within the last 10 years excluding cervical carcinoma in situ or basal cell carcinoma
Pregnancy (self reported)
Study Locations And Contact Information
University of Virginia, Charlottesville Virginia
Contact: Heather Lothamer MSN 434-924-9924 firstname.lastname@example.org
Your browser is currently blocking ads. We depend on ad sponsorships in order to keep this site free to the healthcare provider community. Help us keep this site free by turning off your ad blocker.
Turn Off Ad Blocker
We have detected that you are currently blocking ads. We kindly ask that you enable ads when visiting our site. We depend on ad sponsorships in order to keep this site free to the healthcare provider community.